Emuric Pharmaceuticals Private Limited
About Emuric Pharmaceuticals Private Limited
Data last updated:
Emuric Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 13 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U85190BR2016PTC031778. Its GSTIN is 10AAECE3155B1ZH (Bihar). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rahul Kumar and Ravi Ranjan Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S/O Ramnaresh Singh Jai Nagar Colony Gola Road Digha Dc2 Digha Patna, Bihar, India – 801503.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.9 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net loss of ₹7.22 Lakh (net margin -38.2%) and EBITDA of -₹7.22 Lakh (EBITDA margin -38.2%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Emuric Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS/O Ramnaresh Singh Jai Nagar Colony Gola Road Digha Dc2 Digha Patna, Bihar, India – 801503
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Emuric Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Emuric Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Emuric Pharmaceuticals Private Limited, buy the company report.
Financials of Emuric Pharmaceuticals Private Limited
FY 2025 filings availableEmuric Pharmaceuticals Private Limited reported revenue of ₹18.9 Lakh (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -38.2% | ||||
| Net Profit Margin | -38.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emuric Pharmaceuticals Private Limited, buy the company report.
Board of directors of Emuric Pharmaceuticals Private Limited
Emuric Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Kumar Also directs: Empiric Pharmaceuticals Private Limited | Director | 22 Aug 2020 | 6 Years 2 Months | Current |
| Ravi Ranjan Singh | Director | 13 Jun 2016 | 10 Years 4 Months | Current |
| Avinash Kumar Also directs: Sarfans Vegan Food Products Private Limited | Director | 13 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Emuric Pharmaceuticals Private Limited is audited by MANOJ MOHAN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ MOHAN & ASSOCIATES | FY 2017 | 513929 |
Shareholding
The shareholding of Emuric Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Emuric Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Emuric Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emuric Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Emuric Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECE3155B1ZH | Bihar | Active | 01 Jul 2017 |
| 20AAECE3155B1ZG | Jharkhand | Active | 29 Jul 2021 |
To see the full GST registrations and return filing status of Emuric Pharmaceuticals Private Limited, buy the company report.
Recent activity
Emuric Pharmaceuticals Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Rahul Kumar was appointed as Director on 22 Aug 2020.
Frequently asked questions
Emuric Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 13 June 2016 (10+ years old) and is registered under CIN U85190BR2016PTC031778.
Emuric Pharmaceuticals has 3 current directors:
- Rahul Kumar - Director
- Ravi Ranjan Singh - Director
- Avinash Kumar - Director
The latest financial statements of Emuric Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Emuric Pharmaceuticals is 10AAECE3155B1ZH, registered in Bihar. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 20AAECE3155B1ZG (Jharkhand).
The CIN (Corporate Identification Number) of Emuric Pharmaceuticals is U85190BR2016PTC031778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emuric Pharmaceuticals was incorporated on 13 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
Rahul Kumar was appointed as Director on 22 Aug 2020. Rahul Kumar ceased to be Director on 11 Mar 2019. Sunita Kumari ceased to be Director on 25 Jun 2018. Emuric Pharmaceuticals has 5 board changes on record in total.
The registered office of Emuric Pharmaceuticals is at SO Ramnaresh Singh Jai Nagar Colony Gola Road Digha Dc2 Digha Patna, Bihar, India – 801503.
Emuric Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Emuric Pharmaceuticals is compliant as of 23 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
